We've found
6,982
archived clinical trials in
Endocrine
We've found
6,982
archived clinical trials in
Endocrine
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Updated: 3/21/2014
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Click here to add this to my saved trials
Investigating Markers of Energy Metabolism in the CNS and Periphery in Pregnant Women With Varying Degrees of Insulin Resistance
Status: Enrolling
Updated: 4/8/2014
Updated: 4/8/2014
Investigating Markers of Energy Metabolism in the CNS and Periphery in Pregnant Women With Varying Degrees of Insulin Resistance
Status: Enrolling
Updated: 4/8/2014
Updated: 4/8/2014
Click here to add this to my saved trials
Effects of Calorie Restriction on Accumulation of Old, Modified Proteins in Abdominally Obese Adults
Updated: 4/9/2014
Effects of Calorie Restriction on Accumulation of Old, Modified Proteins in Abdominally Obese Adults
Status: Enrolling
Updated: 4/9/2014
Effects of Calorie Restriction on Accumulation of Old, Modified Proteins in Abdominally Obese Adults
Updated: 4/9/2014
Effects of Calorie Restriction on Accumulation of Old, Modified Proteins in Abdominally Obese Adults
Status: Enrolling
Updated: 4/9/2014
Click here to add this to my saved trials
Modulation of Insulin Sensitivity by Betaine Upregulation of FGF21
Updated: 4/15/2014
Modulation of Insulin Sensitivity by Betaine Upregulation of FGF21
Status: Enrolling
Updated: 4/15/2014
Modulation of Insulin Sensitivity by Betaine Upregulation of FGF21
Updated: 4/15/2014
Modulation of Insulin Sensitivity by Betaine Upregulation of FGF21
Status: Enrolling
Updated: 4/15/2014
Click here to add this to my saved trials
Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease
Updated: 5/20/2014
Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease (KXK005).
Status: Enrolling
Updated: 5/20/2014
Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease
Updated: 5/20/2014
Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease (KXK005).
Status: Enrolling
Updated: 5/20/2014
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
Updated: 7/1/2014
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Click here to add this to my saved trials
Metabolic Actions of Omega-3 Fatty Acids
Updated: 7/2/2014
Metabolic Actions of Omega-3 Fatty Acids on Inflammation and Adipocyte Lipolysis in the Metabolic Syndrome
Status: Enrolling
Updated: 7/2/2014
Metabolic Actions of Omega-3 Fatty Acids
Updated: 7/2/2014
Metabolic Actions of Omega-3 Fatty Acids on Inflammation and Adipocyte Lipolysis in the Metabolic Syndrome
Status: Enrolling
Updated: 7/2/2014
Click here to add this to my saved trials
Metabolic Actions of Omega-3 Fatty Acids
Updated: 7/2/2014
Metabolic Actions of Omega-3 Fatty Acids on Inflammation and Adipocyte Lipolysis in the Metabolic Syndrome
Status: Enrolling
Updated: 7/2/2014
Metabolic Actions of Omega-3 Fatty Acids
Updated: 7/2/2014
Metabolic Actions of Omega-3 Fatty Acids on Inflammation and Adipocyte Lipolysis in the Metabolic Syndrome
Status: Enrolling
Updated: 7/2/2014
Click here to add this to my saved trials